All Disease Treatment & Prevention articles
-
NewsGrowing evidence that sugar substitutes disrupt gut health and metabolism
In a new review, researchers noted that artificial and other low-calorie sweeteners, compared to non-caloric controls such as water or placebo, raised fasting insulin and HbA1c, a marker of long-term blood sugar control, and showed a trend toward worsening insulin sensitivity.
-
NewsCommon probiotic ingredient turns immune cells into tumor killers
A probiotic bacterium secretes mannose—that significantly suppresses melanoma growth in mice by activating the body’s own immune defenses. Mannose enters CD8⁺ T cells through glucose transporters and inhibits a key protein called YAP1, which normally restrains T-cell killing power.
-
![Low-Res_[1] KRICT Research Team](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/3/0/4/21304_lowres_1krictresearchteam_295027.jpg)
NewsKRICT discovers novel SRV2 envelope protein for efficient car immune cell production
Researchers identify a novel SRV2 envelope protein that serves as a key to unlock immune cells, enabling more efficient delivery of anticancer genes and improving the production and therapeutic performance of CAR immune cells.
-
NewsGut microbiome: The hidden architect of liver cancer immunotherapy response
A comprehensive review synthesizes current advances linking gut bacteria to immunotherapy outcomes in hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
-
NewsAntibiotics reverse damage caused to blood stem cells by chronic Salmonella
A new study has revealed that long-term Salmonella infections severely damage blood stem cells - but this damage is completely reversible. Giving an effective course of antibiotics fully restores the stem cells, allowing them to recover their health and rebuilding power.
-
NewsBack in action: Researchers make drug-resistant bacteria vulnerable again
New findings show that disabling a single bacterial protein can restore vancomycin’s power against resistant bacteria – and point to a new strategy for overcoming antibiotic resistance.
-
NewsDiabetes worsens long COVID complications
In a study involving 870 participants, people with diabetes took longer to recover from the virus and experienced more severe cardiac complications, as well as greater physical and cognitive difficulties.
-
NewsCryo-EM helps identify the mechanisms of dental plaque formation
Researchers used cryo-electron microscopy to provide new insights into how Porphyromonas gingivalis causes plaque formation, revealing the 3D structure of Mfa pili, an arm-like filament which enables the bacteria to stick to host tissues and other microbes.
-
NewsResearchers affirm long-held belief that viruses can trigger Parkinson’s disease
Researchers have developed a model that uses a nontoxic way to generate the symptoms of Parkinson’s: infection with a virus. It proves that a simple viral infection can trigger the exact brain damage and physical disabilities in animal models that are seen in people with Parkinson’s disease.
-
NewsMount Sinai scientists develop first fully human monoclonal antibody cocktail that protects against Nipah and Hendra viruses
New preclinical study demonstrates that a novel monoclonal antibody cocktail provides complete protection against lethal Nipah and Hendra virus infection.
-
NewsProbiotic bacteria Lactobacillus rhamnosus alleviates diabetic nephropathy in rat models
A recent study demonstrates that the probiotic strain Lactobacillus rhamnosus exerts significant renoprotective effects rat models of diabetic nephropathy.
-
NewsClimate change could reshape flu seasons across the Americas
Researchers find that weather and climate patterns can help predict the timing and severity of flu outbreaks across diverse regions.
-
NewsGut microbiome could hold important clues as to how IBD develops and progresses
The gut microbiome could hold important clues as to how IBD develops and progresses – and which treatment is best suited to individual patients.
-
NewsReview unmasks hidden role of gut microbes in colorectal cancer
A new review systematically dissects how the gut microbiota and host cells talk to each other across four molecular layers – genome, transcriptome, epigenome, and metabolome – and highlights the computational innovations that make such multi‑omics integration possible.
-
NewsPersistent herpes zoster-associated pain: New review uncovers mechanisms and supports earlier intervention
For millions, herpes zoster pain does not end when the rash fades. Postherpetic neuralgia can last for years, devastating quality of life. A comprehensive review has mapped the full cascade of mechanisms driving this persistent pain, providing support for earlier, more aggressive treatment.
-
NewsEnvironmental fungi found to alter vaginal mycobiome and cervical disease progression during dysbiosis
Scientists have demonstrated for the first time that environmental fungi actively interact with the vaginal bacteriome and mycobiome with likely implications for cervical disease progression.
-
NewsLandmark study reveals ‘megacluster’ of bacterial genes behind arsenal of potent antibiotics
A newly discovered “megacluster” of genes in Streptomyces bacteria produces four new natural product antibiotics that work together to stop rival bacteria.
-
NewsBiofilm “scaffolds” protect bacterium responsible for food poisoning from antibiotics
Bacillus cereus, which is responsible for human infections and food poisoning, builds organized communities that act as a ‘shield’ against antibiotics, a new study reveals.
-
NewsMicrobes rewrite the rules of cancer immunotherapy by triggering immunogenic cell death
A new study reveals that microbiota and their metabolites can effectively reprogram immunogenic cell death (ICD), a unique form of cell death that activates the body‘s immune system against tumors, transforming immunologically “cold” therapy-resistant tumors into “hot” responsive ones.
-
NewsRight versus left: Colorectal cancer’s two microbial worlds
New research reveals that the mucosal microbiome varies dramatically depending on whether a tumor arises on the right or left side of the colorectum, suggesting that the microbial environment surrounding tumors may be as geographically distinct as the tumors themselves.